// App-Quantinova.ai

P3-03-13 : Chronic inhibition of signal transducer and activator of transcription 3/5 in treatment-resistant human breast cancer cell subtypes: Convergence on the reactive oxyten species/SUMOylation pathway and its effects on xCT expression and system x activity

Researchers

Presenter

  • K Linher-Melville

Principal Investigators

  • MG Nashed

  • R Ungard

  • S Haftchenary

  • PT Gunning

  • G Singh

Medical Centers

  • University of Toronto Mississauga, Mississauga, Ontario, Canada

  • McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • capsazepine

  • Paclitaxel

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved